Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses

Journal: Science Advances

Published: 2019-12-01

DOI: 10.1126/sciadv.aax9586

Affiliations: 13

Authors: 23

Go to article
Institutions Share
Syntimmune, Inc., United States of America (USA) 0.22
Division of Gastroenterology, Hepatology and Endoscopy, BWH, United States of America (USA) 0.15
Biologics Consulting, United States of America (USA) 0.13
BioProcess Technology Consultants, United States of America (USA) 0.09
Abzena PLC, United Kingdom (UK) 0.09
New York Structural Biology Center (NYSBC), United States of America (USA) 0.09
The Jackson Laboratory (JAX), United States of America (USA) 0.09
BioBridges, United States of America (USA) 0.04
Clinical Pharmacology of Miami, United States of America (USA) 0.04
Division of Gastroenterology, Hepatology and Nutrition, BCH, United States of America (USA) 0.02
UiO Centre for Immune Regulation (CIR), Norway 0.01
Oslo University Hospital (OUS), Norway 0.01
UiO Department of Pharmacology (FAR), Norway 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER